Validity of a Belt Mounted Accelerometer to Assess Walking Measures in Patients With Chronic Stroke

Sponsor
University of Winchester (Other)
Overall Status
Suspended
CT.gov ID
NCT04288960
Collaborator
(none)
20
1
3.9
5.1

Study Details

Study Description

Brief Summary

The aim of this study is to validate the G-walk for several gait parameters, tested against a gold standard three dimensional camera system. This research will inform researchers and practitioners as to whether the G-Walk is a suitable and valid tool to easily assess walking ability in people with chronic stroke.

Condition or Disease Intervention/Treatment Phase
  • Device: Gwalk accelerometer walking trials

Detailed Description

Twenty chronic stroke survivors will be recruited for this study from an independent neuro-physiotherapy practice and community exercise programme.Gait analysis will be used to look at several gait parameters through the use of a three-dimensional visual analysis system based in our Biomechanics Lab at the University of Winchester. Participants will attend testing one testing session of approximately 1 hour. During this testing session functional measures and walking trials will be assessed. Participants will first be asked to complete a set of simple movements that will contribute towards Fugl Meyer questionnaire. Twenty eight reflective markers will then be attached to specified joints and segments of the body, such as the thigh, with double sided sticky tape to allow for data collection through the camera system to collect kinematic data. The belt mounted accelerometer (G-Walk) will be positioned around the waist over the L5 vertebrae. Participants will be asked to perform 6 walking trials of 10m to collect 3D kinematic and accelerometer gait data.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Validity of a Belt Mounted Accelerometer to Assess Walking Measures in Patients With Chronic Stroke
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Chronic Stroke

Twenty chronic stroke patients (>3months post-stroke) will complete a one off session in a biomechanics lab. This session will include the Fugl Meyer Questionnaire and several walking trials along a flat, level 10m walkway. During this participants will wear a belt mounted accelerometer and small reflective markers on joints.

Device: Gwalk accelerometer walking trials
No intervention. Participants will wear a belt mounted accelerometer and complete walking trials to assess validity of the device

Outcome Measures

Primary Outcome Measures

  1. Speed [60 minutes]

    How quickly a participant walks overground

  2. Cadence [60 minutes]

    Steps taken per minute

  3. Stride Length [60 minutes]

    The distance between strides

  4. Swing phase duration [60 minutes]

    Percentage of the gait cycle spent in swing phase

  5. Stance phase duration [60 minutes]

    Percentage of the gait cycle spent in stance phase

  6. Gait cycle duration [60 minutes]

    The time it takes to complete one gait cycle

  7. Double support duration [60 minutes]

    Percentage of the gait cycle spend with both feet on the ground (double support)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • <3 months post stroke

  • Lower limb impairment

  • Able to stand and step independently

  • Functional ambulation classifications (FAC) of 2-5

  • Modified Rankin Scale (MRS) of 1-3

  • Cognitively aware to undertake the testing session

Exclusion Criteria:
  • Unresolved deep vein thrombosis

  • unstable cardiovascular conditions

  • open wounds

  • active drug resistant infection

  • recent fractures of involved limb

  • peripheral arterial disease

  • incontinence

  • severe osteoporosis

  • non-weight bearing.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Winchester Winchester Hampshire United Kingdom SO224NR

Sponsors and Collaborators

  • University of Winchester

Investigators

  • Principal Investigator: Amy Wright, MSc, University of Winchester

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Winchester
ClinicalTrials.gov Identifier:
NCT04288960
Other Study ID Numbers:
  • Wright_Validity_GWalk
First Posted:
Feb 28, 2020
Last Update Posted:
May 26, 2022
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Winchester
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 26, 2022